Princeton-based Calyptus Pharmaceuticals Inc. announced Aug. 22 that it entered into an agreement with Provepharm SAS to accelerate development of its complex injectable product used in acute care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback